Introduction
============

Body composition changes with aging, even in relatively healthy elderly. From middle adulthood, height declines, while body weight initially increases, then also declines from around the age of 65 years.[@b1-cia-6-067],[@b2-cia-6-067] These body weight changes reflect changes in body composition. After middle age fat mass (FM) gradually increases while lean tissue mass (LTM) decreases.[@b3-cia-6-067],[@b4-cia-6-067] Marked age-related loss of skeletal muscle mass (SMM) is known as sarcopenia and is associated with loss of strength, functional impairment, and disability.[@b5-cia-6-067],[@b6-cia-6-067]

Sarcopenia has proved difficult to define. Baumgartner[@b7-cia-6-067] used absolute terms, defining sarcopenia as present when appendicular skeletal muscle mass (ASM) normalized for (height)[@b2-cia-6-067] falls below two standard deviations (SD) of the sex-specific mean for a young adult reference population. In contrast, Janssen[@b8-cia-6-067] used relative terms, defining sarcopenia as % SMM adjusted for weight and using cut points (\<1 or \<2 SD) drawn relative to the sex-specific mean of a young adult reference group. By either method, sarcopenia is independently associated with self-reported functional impairment and physical disability.[@b7-cia-6-067],[@b8-cia-6-067]

As SMM declines with aging, muscle strength also decreases.[@b9-cia-6-067] This relationship is nonlinear so that over time, the strength decline exceeds the decline in SMM by a factor of 3:1,[@b9-cia-6-067] and SMM no longer closely reflects muscle strength.[@b9-cia-6-067]--[@b11-cia-6-067] The question therefore arises as to whether muscle strength is a more important determinant of physical function and disability than the quantity of SMM[@b12-cia-6-067],[@b13-cia-6-067] in elderly women.

To date, most studies on body composition and physical function in the elderly have focused on healthy, community dwelling individuals.[@b7-cia-6-067]--[@b9-cia-6-067],[@b11-cia-6-067]--[@b13-cia-6-067] Few have investigated institutionalized elderly who, by virtue of their need for care, are more likely to exhibit sarcopenia and physical impairment than their community dwelling counterparts.[@b14-cia-6-067] In Australia, one in three who live in aged care accommodation reside in low-level care facilities.[@b15-cia-6-067] Despite their semi-independent status, relative mobility, and capacity for self-care, there is a high prevalence of malnutrition,[@b16-cia-6-067] which is a risk factor for sarcopenia.[@b5-cia-6-067] Moreover, the detection of sarcopenia and/or reduced muscle strength in these elderly is important as a predictor of morbidity risk and need for higher level care.[@b17-cia-6-067]

Physical function in elderly people has been assessed by the timed 'up and go' test (TUG), and by walking speed over 6 meters (WS). TUG is considered a satisfactory measurement of balance in the elderly,[@b18-cia-6-067] while WS is reflective of general well being.[@b19-cia-6-067] Both measures are more objective than the self-reported activity measures frequently used in studies in the elderly[@b18-cia-6-067] and both have well established risk identification cut points.[@b19-cia-6-067]--[@b22-cia-6-067] The objectives of this study were to measure body composition by the optimal measure of dual energy X-ray absorptiometry (DXA),[@b23-cia-6-067] in elderly Australian women living in low-level care accommodation; to determine the prevalence of sarcopenia (defined in absolute or relative terms) and to investigate relationships among body composition, muscle strength, and physical function.

Materials and methods
=====================

Study design and participants
-----------------------------

Participants were Caucasian women residing in low-level aged care facilities in metropolitan Melbourne, Australia. Low-level care caters for semi-independent ambulatory elderly who are 'relatively healthy', as distinct from high-level care which caters for those with severe chronic illness and/or disability.[@b24-cia-6-067] An assessment of medical, physical, social, and psychological needs is first made to determine eligibility for entrance to care. Low-level care facilities in Australia typically provide a lower level of nursing support and provide fewer allied health services such as physiotherapy and podiatry relative to high-level care. Data were obtained at the initial assessment of elderly women from 14 low-level aged care hostels who were recruited into a two-year cluster randomized control trial.[@b16-cia-6-067] Women were enrolled if they were ambulatory and able to self-feed. Women were excluded only if they were non-Caucasian or unable to communicate in English. As a consequence of their residential status, all received considerable assistance with daily activities whether this was required or not. While 78 women were recruited, this study consists of the 63 women for whom DXA data were complete. The 15 women with missing data were of similar age and body mass index (BMI) to those studied (data not shown). The study was approved by the Human Research Ethics Committee, Austin Health and by the Standing Committee on Ethics in Research involving Humans, Monash University.

Young adult reference group
---------------------------

As there are no published standard values for body composition for Australian adults, and no single set of accepted definitions for sarcopenia, local reference population data were acquired and used to determine cut-off values for sarcopenia. Data were obtained from 62 apparently healthy, nonsmoking Caucasian women aged 18--40 years and with BMI 17.9--35.4 kg/m^2^ who were recruited from the local community.[@b25-cia-6-067] Their body composition was determined by DXA as described also for the elderly female cohort (see below). Young women were excluded from this reference group if they currently smoked, were non-Caucasian, had a history of reduced bone mineral density or osteoporotic fractures, had used oral or intravenous corticosteroids, or were pregnant.

Muscle strength assessment
--------------------------

Muscle strength was assessed by an objective method: determination of the maximal isometric strength of the ankle dorsiflexers, knee extensors, and hip abductors on both legs using a hand held dynamometer -- the Nicholas Manual Muscle Tester (NMMT; Lafayette Instruments, Lafayette, IN).[@b26-cia-6-067] One experienced technician (BK) performed all strength assessments on 53 elderly women. Women with missing data were of similar age and body composition (data not shown). The NMMT quantifies the breaking force (in kg) necessary to depress a limb when held in a specific position. Each muscle group on the right and left legs was assessed in two separate trials and the average maximal force observed at each site was used for analysis. Each average maximal force (in kg) was multiplied by 9.81 to convert it to newtons (N), then divided by body weight (kg) to provide a measure of isometric strength (N/kg).[@b27-cia-6-067] The intraclass correlation coefficient of all measures was above 0.93 (*P* \< 0.001), indicating high reproducibility.[@b28-cia-6-067]

Isometric strength testing measures static muscle force and does not take into account dynamic muscle performance which includes muscle work, muscle power, and muscle impulse, as in isokinetic strength measurement. Hence, isometric strength does not necessarily reflect the strength an individual might exhibit in a dynamic test.[@b29-cia-6-067] However, isometric strength testing of the lower extremity, using a hand held device has been found to be both reliable and valid in older people.[@b30-cia-6-067]

Assessment of physical function
-------------------------------

Physical function was determined by TUG and WS over a 6 m distance as described by Hill et al.[@b26-cia-6-067] TUG reflects the time in seconds taken to stand from a seated position, walk 3 m, turn around, walk back, and sit down again. To determine WS, women walk at a comfortable speed over 8 m while the time taken (in seconds) to walk the central 6 m is recorded. A walking speed (m/second) is then calculated. One technician (BK) performed all function tests.

Anthropometry
-------------

Body weight was measured to ± 0.1 kg on an electronic scale (SECA, Hamburg, Germany) with participants wearing light indoor clothing and no shoes. Standing height was measured using a stadiometer (Holtain, Crosswell, UK). BMI was calculated as weight divided by height squared (kg/m^2^). Underweight was defined as BMI \< 20 kg/m^2^, normal weight as BMI 20--24.9 kg/m^2^, overweight as BMI 25--29.9 kg/m^2^, and obesity as BMI \>30 kg/m^2^. In [Figure 1](#f1-cia-6-067){ref-type="fig"}, BMI \< 25 kg/m^2^ is described as 'lean'.

Dual-energy X-ray absorptiometry
--------------------------------

Elderly participants and the young reference population underwent whole body DXA scans to provide estimates of LTM and FM (Prodigy, Version 7.51; GE Lunar, Madison, WI and DPX-IQ, software version 4.7e; Lunar Radiation Corporation, Madison, WI, respectively) using the standardized procedures of the manufacturer. These machines provide similar measures of body composition.[@b31-cia-6-067]--[@b33-cia-6-067] Calibration against a standard block was performed daily, while precision monitoring against a standard lumbar spine bone mineral density phantom was undertaken weekly. No systematic long-term bias was evident in the phantom data. DXA scans were analysed by a single radiographer for each study group. Appendicular skeletal muscle mass (ASM) was calculated from the sum of LTM for the arms plus legs.[@b34-cia-6-067] Total skeletal muscle mass (SMM) was determined from ASM using the predictive equation of Kim: $$\text{Total}~\text{SMM}~(\text{kg}) = (1.13~ \times ~\text{ASM})~ - ~(0.02~ \times ~\text{age})~ + (0.61~ \times ~\text{sex})~ + ~0.97$$where sex = 0 for females.[@b35-cia-6-067]

Body composition indices
------------------------

To determine absolute sarcopenia, ASM was adjusted for stature (ASM/height squared (kg/m^2^)).[@b7-cia-6-067] Percentage skeletal muscle (SMI%) was computed as (SMM/weight (kg) × 100), to determine relative sarcopenia, after calculation of SMM as above from DXA-derived ASM.[@b35-cia-6-067] Three categories of sarcopenia were defined; *normal* if ASM/ht^2^ or SMI% were \<1 SD from the mean of the young reference group; *class I sarcopenia* if the index fell between \>1 SD and \<2 SD; and *class II sarcopenia* if the index was \<2 SD below the mean for the young reference group.[@b8-cia-6-067]

Other covariates
----------------

Age (in years) was calculated as the difference between the date of examination and date of birth. Comorbidity was defined as the number of current chronic conditions based on medical record report of cardiovascular disease, stroke, cancer, diabetes, arthritis, kidney disease, or lung disease. A registered nurse recorded disease conditions from the medical records maintained at each facility.

Data analysis
-------------

Data were analysed using SPSS for Windows (Version 16; SPSS Australasia Ltd, Melbourne, Australia). Continuous data were checked for normality, outlying scores, and missing data. Nonnormal data were transformed and outliers transformed to one unit above/below the next most extreme score. Descriptive data are given as the mean ± SD or as percentages. Differences between groups were tested via Student's unpaired *t*-test, differences for categorical data were tested via the χ^2^ test and relationships among variables were examined using Pearson's correlation. As missing values occurred at random (as indicated by Little's χ^2^ test), missing data points were estimated by an expectation maximization algorithm,[@b36-cia-6-067] before undertaking multivariate analyses. A value of *P* \< 0.05 was taken as significant.

Results
=======

All 63 elderly study participants were ambulatory although 56% had arthritis. Cardiovascular disease, lung disease, and renal disease were present in 38%, 11%, and 8%, respectively, while 13% had previously had cancer and 6% had diabetes. None of the women had GP-diagnosed active cancer at the time of assessment. Medical conditions were found not to be associated with age, body composition, strength, or physical functioning (data not shown). The body composition of these elderly women was compared to that of a young, healthy female reference population ([Table 1](#t1-cia-6-067){ref-type="table"}).

Although body weight did not differ, the elderly were significantly shorter (*P* \< 0.001) and had higher mean BMI (*P* \< 0.001), lower LTM (*P* \< 0.001), but higher total FM (*P* \< 0.01). ASM/ht^2^ was similar to that of the younger women indicating that their lower level of LTM supported a similar weight but a higher FM. In contrast, SMI% was significantly lower in older women (*P* \< 0.001). [Table 1](#t1-cia-6-067){ref-type="table"} also provides strength and function measures for the elderly group. Here, those above the median age of 86 years had significantly lower strength, WS, and TUG than younger elderly (all *P* \< 0.01, data not shown).

The mean ASM/ht^2^ for the young reference group was 6.31 ± 0.73 kg/m^2^ yielding cut-off values for normal ASM/ht^2^, class I, and class II sarcopenia of \>5.58 kg/m^2^, 4.85--5.58 kg/m^2^, and \<4.85 kg/m^2^, respectively. The mean SMI% for the young reference group was 32.91 ± 4.56% providing corresponding cut-off values for normal SMI%, class I, and class II sarcopenia of \>28.4%, 23.8%--28.4%, and \<23.8%, respectively. [Table 2](#t2-cia-6-067){ref-type="table"} shows the proportion of the elderly population categorized according to these cut-off values.

[Figure 1](#f1-cia-6-067){ref-type="fig"} compares the prevalence of absolute (ASM/ht^2^) versus relative (SMI%) sarcopenia according to BMI. Only 3.2% of the women were underweight, 38.1% were of normal weight, 39.7% were overweight while 19% were obese. Defining sarcopenia by ASM/ht^2^ identified few women (3.2%) as sarcopenic, all of whom were lean, with a mean BMI of 24.4 kg/m^2^. Defining sarcopenia with SMI% identified more women (36.5%), the majority of whom were overweight or obese, with a mean BMI of 29.1 kg/m^2^. Absolute sarcopenia was prevalent in significantly more lean women (*P* \< 0.001), whilst relative sarcopenia was more prevalent in overweight and obese women (*P* \< 0.01).

The two measures of physical function used in this study TUG and WS, were strongly related to each other (*r* = 0.699, *P* \< 0.001). Age-adjusted relationships between these two function outcomes and measures of body composition and sarcopenia are presented in [Table 3](#t3-cia-6-067){ref-type="table"}.

TUG and WS were most strongly associated with hip abductor strength (*r* = −0.42, *P* \< 0.01 and *r* = 0.47, *P* \< 0.001, respectively). While both measures were also associated with ankle dorsiflexor strength (*r* = −0.31, and *r* = 0.34, both *P* \< 0.05, respectively), only WS was related to knee extensor strength (*r* = −0.23, *P* \< 0.05). Neither TUG nor WS were found to be related to any measures of body composition. TUG also showed an unexpected positive association with absolute sarcopenia (*r* = 0.28, *P* \< 0.05).

Women with the highest physical function (in the tertile with shortest TUG and quickest WS) were next compared with women with the poorest physical function (the tertile with longest TUG and slowest WS) ([Table 4](#t4-cia-6-067){ref-type="table"}).

The women with poor physical function were significantly older (*P* \< 0.01) and had significantly lower strength measures at each site (*P* \< 0.05 at ankle and knee; *P* \< 0.01 at the hip). There were however, no differences in BMI, SMI, or measures of body composition between the two groups. ASM/ht^2^ was significantly higher (*P* \< 0.05) in the women with poor physical function consistent with the weak positive relationship found between ASM/ht^2^ and TUG ([Table 3](#t3-cia-6-067){ref-type="table"}). Yet the higher ASM/ht^2^ in the women with poor physical function did not reflect significant difference in ASM but rather appeared related to differences in body height since women with poor physical function tended to be shorter (*P* = 0.07).

In a multivariate model including ankle, knee, and hip measures of strength, only hip abductor strength predicted TUG and WS (both *P* ≤ 0.05), explaining 6.6% and 7.3% of the variation respectively (Model A, [Table 5](#t5-cia-6-067){ref-type="table"}). Addition of age and LTM (model B) resulted in a small increase in the total *R*^2^ value of the model: for TUG, *R*^2^ increased from 19%--25% (*P* \< 0.01) while for WS, *R*^2^ increased from 22%--28% (*P* \< 0.01). Again, the only statistically significant strength measure was that of the hip abductors, explaining 10.3% of the variation in TUG and 10.5% of the variation in WS (both *P* = 0.01, Model B, [Table 5](#t5-cia-6-067){ref-type="table"}). Age was a predictor of WS (*P* \< 0.05) and also tended to predict TUG (*P* = 0.08) while LTM was not a predictor of physical function. In further analyses, both absolute and relative sarcopenia indices were also not predictors of physical function (data not shown).

Discussion
==========

This study examines sarcopenia and physical function in elderly Australian women living in low-level aged care. Two common indices of sarcopenia, ASM/ht^2^ and SMI% defined different populations. Only ASM/ht^2^ showed any association with physical function (TUG, [Table 3](#t3-cia-6-067){ref-type="table"}) and this association was weak, in an unexpected positive direction and might be explained by differences in body height ([Table 4](#t4-cia-6-067){ref-type="table"}). Elderly women were shorter than younger women, possibly as a result of vertebral compression following reduced bone mineral density.[@b37-cia-6-067] Comparisons between women of high versus poor physical function indicated clear differences in ankle, knee, and especially hip strength but none in body composition ([Table 4](#t4-cia-6-067){ref-type="table"}). Moreover, hip strength was a significant predictor of physical function. Hip strength therefore appears to be a more important indicator of physical function in this population than measures of muscle quantity (defined by LTM or sarcopenic indices).

Our population of elderly women had clearly different body composition from the young women used as a reference group. These differences of reduced muscle mass, increased FM, and increased percentage total fat are consistent with previous reports.^2^,[@b3-cia-6-067],[@b38-cia-6-067] Additionally, the relatively high prevalence of overweight and obesity in our elderly women was comparable with that seen in other elderly women residing at home[@b39-cia-6-067],[@b40-cia-6-067] or in aged care.[@b41-cia-6-067] Their low LTM was also similar to that found in healthy community-dwelling elderly women.[@b42-cia-6-067]

The reported prevalence of sarcopenia in elderly populations differs with age and gender, the definition of sarcopenia applied and the normative data used for comparison. We compared the absolute method of Baumgartner[@b7-cia-6-067] with the relative method of Janssen.[@b8-cia-6-067] In the absence of universally accepted reference ranges[@b42-cia-6-067] and the presence of ethnic differences,[@b43-cia-6-067] cut-off values should be selected from an ethnically similar, local reference population who have been measured in a similar way, using a similar DXA scanner.[@b44-cia-6-067] The use of Australian reference data from a population with similar height and weight to the general Australian Caucasian population,[@b45-cia-6-067] is one strength of our study. In contrast, reference populations used by Baumgartner[@b7-cia-6-067] and Janssen[@b8-cia-6-067] included African Americans and Mexican Americans who differ in LTM,[@b4-cia-6-067],[@b46-cia-6-067] and infrequently live in Australia. Among other reference populations,[@b7-cia-6-067],[@b8-cia-6-067],[@b40-cia-6-067] only those from Italy[@b40-cia-6-067] align with those we report here, which justifies the application of our own cutoffs for sarcopenia.

Reported prevalence of sarcopenia in elderly populations ranges from 5%--50%.[@b47-cia-6-067] Applying Australian cut-off values, 3.2% of our elderly women had absolute sarcopenia. This is lower than in America or in Europe where prevalence ranges between 16%--43%[@b3-cia-6-067],[@b48-cia-6-067],[@b49-cia-6-067] and 9.5%--12.3%,[@b2-cia-6-067],[@b38-cia-6-067],[@b50-cia-6-067] respectively. In addition, 42.9% of our elderly women had relative sarcopenia, class I, while 36.5% had relative sarcopenia, class II. The prevalence of class II sarcopenia is higher than the 10% reported by Janssen[@b8-cia-6-067] or the 21% approximated from Estrada.[@b49-cia-6-067] Our data are also consistent with Estrada's finding that relative and absolute measures of sarcopenia define two distinct populations,[@b49-cia-6-067] with absolute sarcopenia more common in lean women and relative sarcopenia more common in overweight or obese women. Where obesity is present the relative measure appears more physiologically and clinically relevant since it is better at detecting reduction in mobility.[@b49-cia-6-067]

Poor physical function can be defined by TUG \> 12 seconds.[@b20-cia-6-067] In our study, 73% of women had TUG \> 12 seconds, intermediate between the prevalence of 91% reported for institutionalized mobile women, and 8% reported for community dwelling elderly women.[@b20-cia-6-067] WS also indicates poor physical function in elderly populations and is predictive of adverse outcomes: those with WS \< 0.6 m/sec are at increased risk of functional decline and death.[@b19-cia-6-067] In our elderly population, 43% of women had WS \< 0.6 m/sec. Mean WS was 0.67 m/sec, appreciably slower than for community dwelling, elderly Australians where the mean WS was 0.99 m/sec.[@b26-cia-6-067] Our results therefore suggest that institutionalized women in low-level care have poorer physical function than women who reside in the community. This is not surprising given that institutionalized women have been assessed as requiring additional care, however, it does signal a higher risk of adverse outcomes and the need for programs to improve physical functioning.

Absolute sarcopenia has been associated with limited physical function in some,[@b7-cia-6-067],[@b8-cia-6-067],[@b51-cia-6-067] but not all,[@b40-cia-6-067],[@b50-cia-6-067] cases where physical function has been measured by self-report. When physical function was measured objectively,[@b49-cia-6-067] little association between absolute sarcopenia and physical function has been evident. In contrast, a relationship between relative sarcopenia and limited physical function has been found regardless of whether physical function was self-reported[@b7-cia-6-067],[@b8-cia-6-067],[@b40-cia-6-067],[@b51-cia-6-067] or measured objectively.[@b49-cia-6-067] In our study, absolute sarcopenia was weakly associated only with TUG but not with WS, while relative sarcopenia was unrelated to either measure ([Table 3](#t3-cia-6-067){ref-type="table"}). The discrepancy with findings in the literature may relate to over- or under-estimation of functional ability with self-reported measures,[@b52-cia-6-067] or may be due to exclusion of some possible confounders when analyses have been performed.

Measures of muscle mass have also been shown to be predictive of muscle function[@b11-cia-6-067],[@b12-cia-6-067],[@b53-cia-6-067] although the association is no longer observed after adjustment for muscle strength.[@b11-cia-6-067],[@b12-cia-6-067] In contrast we found no association between LTM or any other measure of body composition and TUG or WS. Decreased strength, as measured by either knee extensors/flexors or hand grip strength has been associated with worse physical function,[@b9-cia-6-067],[@b11-cia-6-067],[@b12-cia-6-067],[@b53-cia-6-067]--[@b55-cia-6-067] and in all cases except one,[@b53-cia-6-067] muscle mass has been found to be a nonsignificant variable compared with muscle strength. Indeed, Visser has concluded that underlying muscle strength can explain any association between muscle mass and physical function.[@b11-cia-6-067],[@b12-cia-6-067] Most previous studies however, have targeted generally healthy, higher functioning elderly of less advanced age making comparison with our functionally limited, older group difficult.

In our study, the most important variables related to physical function (as assessed by TUG and WS) were ankle, knee, and particularly hip strength ([Table 4](#t4-cia-6-067){ref-type="table"}). In multivariate analyses, only hip abductor strength predicted physical function (although age also predicted WS). Most previous studies assessing leg strength and physical function have used knee extensor/flexor and/or ankle dorsiflexor strength as a proxy for lower extremity strength.[@b55-cia-6-067] Few report the contribution made by differing muscle groups to physical function. Here we assess the strength of three different muscle groups, finding that whilst strength in each group was associated with function in univariate analysis, once all measures were taken into account, only hip abductors were significantly associated with function. All three muscle groups examined are important for normal gait and strength deficiencies in any group affect gait and gait speed. Poor hip abductor strength affects pelvic stabilization, allowing tilting of the pelvis along with slowing of gait.[@b56-cia-6-067] Hip extensors also appear particularly important for the activities of daily living.[@b27-cia-6-067] The dominant effect of hip strength as reported here has not always been apparent in earlier studies. For example, in one study, strength of hip extensors and abductors was only weakly associated with gait speed and the ability to rise from a chair, although when these measures were combined with measures of leg and ankle strength, and normalized for weight, significant associations with performance emerged.[@b56-cia-6-067] Conditions of loading may have affected these findings. Another study reported that the strength of hip flexors and knee extensors only predicted physical function under conditions of a light load (\<15 kg and \<10 kg, respectively; neither normalized to weight).[@b57-cia-6-067] Rantanen however, in an examination of WS in disabled elderly women, found a load threshold affected knee extensor strength only and not hip flexor strength.[@b58-cia-6-067] No other published studies have assessed hip abductor strength and physical function. Further studies discriminating between specific muscle groups and describing their relative importance in maintaining function in the elderly are therefore now needed.

The strong relationship between strength and physical function evident in our study indicates the importance of maintaining strength in elderly women. Progressive resistance strength training can achieve this.[@b59-cia-6-067],[@b60-cia-6-067] Resistance programs recommended for elderly people usually continue for 8--12 weeks with high intensity exercise 2--3 times per week. As possible adverse effects remain poorly documented, care must be taken in planning and implementing such programs. Nonetheless, resistance training has been used successfully in a group of institutionalized nonagenarians.[@b61-cia-6-067] At present, the Accreditation Standards for Aged Care in Australia make no recommendation for exercise programs or resistance training.[@b62-cia-6-067]

A number of limitations in this study need to be acknowledged. The study is cross-sectional in nature, so causality cannot be imputed. It was also based on a relatively small sample in which those incapable of self consent were not included. Nevertheless, it is the first study to describe body composition by DXA in elderly women in low-level residential care, to estimate the prevalence of sarcopenia by different indices, and to describe the relationships among body composition, muscle strength of different muscle groups, and objectively measured physical function.

In conclusion, this study shows similar body composition parameters and prevalence of sarcopenia, but poorer physical functioning, in elderly women in low-level care to those reported for community-dwelling elderly women. It also demonstrates that in these elderly women, hip strength is a better predictor of physical function rather than muscle mass. As muscle mass and sarcopenic indices were unrelated to physical function, measurement of muscle mass seems an inappropriate screening tool to detect physical function limitations or requirements for additional care in this elderly group. This is consistent with the absence of muscle mass as a criterion to identify frailty in one screening tool.[@b63-cia-6-067] Measurement of muscle strength predicted physical functioning in our present study is clinically simple to perform and appears a better screening tool than muscle mass for an elderly population. Further longitudinal studies in this group using a range of strength measures and taking into account physical activity[@b64-cia-6-067] and fitness are now warranted.
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![ASM/ht^2^ (**A**) or SMI% (**B**) in lean (BMI \< 25.0), overweight (BMI 25.0--29.9) and obese (BMI ≥ 30) in elderly women in low-level care.\
**Abbreviations:** ASM, appendicular skeletal muscle mass; BMI, body mass index; SMI%, skeletal muscle mass index (%).](cia-6-067f1){#f1-cia-6-067}

###### 

Characteristics of elderly institutionalized Australian women compared with a reference group of healthy young Australian women

  **Variable**                                                  **Elderly women (n = 63)**                                 **Young women (n = 62)**
  ------------------------------------------------------------- ---------------------------------------------------------- --------------------------
  Age (yrs)                                                     86.4 ± 5.5[\*\*](#tfn3-cia-6-067){ref-type="table-fn"}     28.8 ± 6.0
  Medical conditions[a](#tfn4-cia-6-067){ref-type="table-fn"}   1.5 ± 1.0                                                  n/a
  Height (m)                                                    1.53 ± 0.07[\*\*](#tfn3-cia-6-067){ref-type="table-fn"}    1.65 ± 0.07
  Weight (kg)                                                   62.1 ± 11.1                                                61.5 ± 11.2
  BMI (kg/m^2^)                                                 26.7 ± 4.5[\*\*](#tfn3-cia-6-067){ref-type="table-fn"}     22.5 ± 3.4
  Total fat (kg)                                                23.2 ± 8.4[\*](#tfn2-cia-6-067){ref-type="table-fn"}       17.9 ± 8.5
  Leg LTM (kg)                                                  11.1 ± 1.8[\*\*](#tfn3-cia-6-067){ref-type="table-fn"}     13.3 ± 2.1
  ASM (kg)                                                      14.4 ± 2.1[\*\*](#tfn3-cia-6-067){ref-type="table-fn"}     17.3 ± 2.8
  LTM (kg)                                                      35.7 ± 4.3[\*\*](#tfn3-cia-6-067){ref-type="table-fn"}     40.3 ± 5.3
  SMM                                                           15.5 ± 2.4[\*\*](#tfn3-cia-6-067){ref-type="table-fn"}     20.0 ± 3.2
  ASM/ht^2^                                                     6.20 ± 0.87                                                6.31 ± 0.73
  SMI%                                                          25.31 ± 3.51[\*\*](#tfn3-cia-6-067){ref-type="table-fn"}   32.91 ± 4.56
  Ankle dorsiflexor strength (N/kg)                             1.59 ± 0.48                                                n/a
  Knee extensor strength (N/kg)                                 1.46 ± 0.46                                                n/a
  Hip abductor strength (N/kg)                                  1.45 ± 0.44                                                n/a
  Walking speed (m/second)                                      0.67 ± 0.2                                                 n/a
  Timed up and go (seconds)                                     17.5 ± 5.9                                                 n/a

**Notes:** Data are mean ± SD.

*P* \< 0.01;

*P* \< 0.001.

Medical conditions confined to those listed in *Methods.*

**Abbreviations:** ASM, appendicular skeletal muscle mass; BMI, body mass index; ht^2^, height squared; LTM, lean soft-tissue mass; SMM, skeletal muscle mass; n/a, not applicable; SMI%, skeletal muscle mass index (%).

###### 

Proportion of elderly institutionalized Australian women categorized according to different body composition indices (n = 63)

  **Indices**              **Percentage (%)**
  ------------------------ --------------------
  ASM/ht^2^ (kg/m^2^)      
     Normal                71.4
     Class I sarcopenia    25.4
     Class II sarcopenia   3.2
  SMI% (kg/kg ×100)        
     Normal                20.6
     Class I sarcopenia    42.9
     Class II sarcopenia   36.5

**Abbreviations:** ASM, appendicular skeletal muscle mass; ht^2^, height squared; SMI%, skeletal muscle mass index (%).

###### 

Relationship between measures of physical function and strength with measures of body composition and sarcopenia in elderly institutionalized Australian women (n = 63). Data show Pearson's correlations. Relationships have been adjusted for age

  **Parameter**                       **Timed up and go (sec)**                           **Walking speed (m/sec)**
  ----------------------------------- --------------------------------------------------- -----------------------------------------------------
  Ankle dorsiflexor strength (N/kg)   −0.31[\*](#tfn8-cia-6-067){ref-type="table-fn"}     0.34[\*](#tfn8-cia-6-067){ref-type="table-fn"}
  Knee extensor strength (N/kg)       −0.22                                               0.23[\*](#tfn8-cia-6-067){ref-type="table-fn"}
  Hip abductor strength (N/kg)        −0.42[\*\*](#tfn9-cia-6-067){ref-type="table-fn"}   0.47[\*\*\*](#tfn10-cia-6-067){ref-type="table-fn"}
  Weight (kg)                         0.13                                                −0.05
  Total fat (kg)                      0.08                                                0.003
  Total LTM (kg)                      0.15                                                −0.08
  ASM/ht^2^ (kg/m^2^)                 0.28[\*](#tfn8-cia-6-067){ref-type="table-fn"}      −0.12
  SMI%                                −0.001                                              0.03

**Notes:**

*P* \< 0.05;

*P* \< 0.01;

*P* \< 0.001.

**Abbreviations:** ASM, appendicular skeletal muscle mass; ht^2^, height squared; LTM, lean soft-tissue mass; SMI%, skeletal muscle mass index (%).

###### 

Elderly women with good physical function compared to poor physical function[a](#tfn16-cia-6-067){ref-type="table-fn"}

  **Variable**                        **Good physical function (n = 15)**   **Poor physical function (n = 10)**
  ----------------------------------- ------------------------------------- ------------------------------------------------------------
  ASM/ht^2^                           5.82 ± 0.76                           6.57 ± 0.95[\*](#tfn13-cia-6-067){ref-type="table-fn"}
  SMI%                                25.4 ± 4.0                            25.4 ± 4.6
  Age (yrs)                           84.5 ± 4.3                            90.0 ± 3.6[\*\*](#tfn14-cia-6-067){ref-type="table-fn"}
  Height (m)                          1.56 ± 6.7                            1.51 ± 4.8
  BMI (kg/m^2^)                       25.1 ± 4.3                            28.0 ± 4.7
  Ankle dorsiflexor strength (N/kg)   1.87 ± 0.53                           1.33 ± 0.50[\*](#tfn13-cia-6-067){ref-type="table-fn"}
  Knee extensor strength (N/kg)       1.69 ± 0.67                           1.26 ± 0.23[\*](#tfn13-cia-6-067){ref-type="table-fn"}
  Hip abductor strength (N/kg)        1.82 ± 0.53                           1.31 ± 0.31[\*\*](#tfn14-cia-6-067){ref-type="table-fn"}
  Total fat (kg)                      22.8 ± 9.0                            23.7 ± 10.5
  LTM (kg)                            35.0 ± 2.4                            36.8 ± 4.8
  ASM (kg)                            14.0 ± 1.4                            15.0 ± 2.4
  Leg LTM (kg)                        10.7 ± 1.2                            11.6 ± 2.1
  Walking speed (m/second)            0.94 ± 0.12                           0.46 ± 0.08[\*\*\*](#tfn15-cia-6-067){ref-type="table-fn"}
  Timed up and go (seconds)           10.5 ± 2.3                            25.6 ± 2.8[\*\*\*](#tfn15-cia-6-067){ref-type="table-fn"}

**Notes:** Data are mean ± SD.

*P* \< 0.05;

*P* \< 0.01;

*P* \< 0.001.

Women with good physical function were in the lowest tertile for TUG and the highest tertile for WS while women with poor physical function were in the highest tertile for TUG and the lowest tertile for WS.

**Abbreviations:** ASM, appendicular skeletal muscle mass; BMI, body mass index; ht^2^, height squared; LTM, lean soft-tissue mass; SMI%, skeletal muscle mass index (%).

###### 

Relationships between muscle strength and TUG or WS explored in a multivariate model

  **Measure**                         **Timed up and go (sec)**             **Walking speed (m/min)**                                                                                                                                                 
  ----------------------------------- --------------------------- --------- ------------------------------------------------------------------- --------------- ------- --------- ------------------------------------------------------------------- -----------------
  **Model A**                                                                                                                                                                                                                                         
  Total model *R*^2^                                              0.19                                                                                                  0.22                                                                          
  *P*-value                                                       0.005                                                                                                 0.002                                                                         
  **Independent variable**            **B**                       ***P***   **Variation explained[a](#tfn19-cia-6-067){ref-type="table-fn"}**   **CI**          **B**   ***P***   **Variation explained[a](#tfn19-cia-6-067){ref-type="table-fn"}**   **CI**
  Ankle dorsiflexor strength (N/kg)   −0.14                       0.40      1.2                                                                 −5.6 to 2.3     0.17    0.29      1.9                                                                 −0.06 to 0.2
  Knee extensor strength (N/kg)       0.03                        0.83      0.08                                                                −3.6 to 4.4     −0.06   0.69      0.3                                                                 −0.16 to 0.11
  Hip abductor strength (N/kg)        0.36                        0.05      6.6                                                                 −9.5 to − 0.1   0.37    0.04      7.3                                                                 0.01 to 0.32
  **Model B**                                                                                                                                                                                                                                         
  Total model *R*^2^                                              0.25                                                                                                  0.28                                                                          
  *P*-value                                                       0.004                                                                                                 0.002                                                                         
  **Independent variable**            **B**                       ***P***   **Variation explained[a](#tfn19-cia-6-067){ref-type="table-fn"}**   **CI**          **B**   ***P***   **Variation explained[a](#tfn19-cia-6-067){ref-type="table-fn"}**   **CI**
  Ankle dorsiflexor strength (N/kg)   0.03                        0.86      0.05                                                                −4.4 to 3.7     0.06    0.73      0.2                                                                 −0.11 to 0.16
  Knee extensor strength (N/kg)       0.10                        0.52      0.7                                                                 −2.7 to 5.4     −0.11   0.49      0.8                                                                 −0.18 to 0.09
  Hip abductor strength (N/kg)        −0.46                       0.01      10.3                                                                −10.9 to −1.3   0.46    0.01      10.5                                                                0.05 to 0.36
  Age (years)                         0.21                        0.08      5.1                                                                 −0.3 to 0.5     −0.27   0.03      8.2                                                                 −0.02 to −0.001
  LTM (kg)                            0.17                        0.17      3.2                                                                 −0.1 to 0.5     −0.07   0.55      0.6                                                                 −0.01 to 0.01

**Notes:**

Percentage of variation explained uniquely by the independent variable after adjustment.

**Abbreviations:** ASM, appendicular skeletal muscle mass; BMI, body mass index; CI, 95% confidence interval; ht^2^, height squared; LTM, lean soft-tissue mass; SMM, skeletal muscle mass; n/a, not applicable; SMI%, skeletal muscle mass index (%); TUG, timed up and go; WS, walking speed.
